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ABSTRACT
Objective: The aim of this placebo-controlled study was to evaluate the effect of various 
inferior turbinate surgery techniques on Eustachian tube dysfunction-related symptoms.
Study Design: Outcomes were evaluated using the Eustachian Tube Dysfunction 
Questionnaire (ETDQ-7) and tympanometry results.
Methods: A total of 72 consecutively blinded and randomized adult patients with enlarged 
inferior turbinates due to persistent year-round rhinitis underwent either a radiofrequency 
ablation, diode laser, microdebrider-assisted inferior turbinoplasty, or sham surgery
procedure. Assessments were conducted prior to surgery and three months subsequent to
the surgery.
Results: In the evaluation of all patients, radiofrequency ablation, microdebrider-assisted
inferior turbinoplasty, and sham surgery procedures decreased the Eustachian Tube 
Dysfunction Questionnaire total score significantly. In a three-way analysis of covariance,
there were no significant differences in the results between sham surgery and any of the 
active treatment procedures. Allergic sensitization, sex, and age had no effect on the 
results either. There were no significant changes in the pre- and postoperative amounts of 
abnormal tympanometry curves or in the pre- and postoperative tympanometric peak 
pressure values in the actively treated patients or in the sham surgery group.
Conclusion: The improvement of Eustachian tube dysfunction-related symptoms due to 
surgery of the anterior half of the inferior turbinate was found to be equal to placebo. The
findings of this study do not support the use of reduction of the anterior half of the inferior 
turbinate as a sole procedure intended to treat the ear symptoms assessed by the ETDQ-7
questionnaire.
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INTRODUCTION 
Inferior turbinate enlargement is one of the main causes of nasal obstruction. Bilateral 
inferior turbinate swelling is due to allergic or nonallergic rhinitis. Intranasal corticosteroids 
are the most important medicine group in the treatment of rhinitis. When medical therapy 
for enlarged inferior turbinates fails, turbinate surgery can be performed.1,2 
 
Eustachian tube dysfunction (ETD) is a common condition in otorhinolaryngology practice. 
Symptoms include fullness or clogging of the ears, pain or discomfort, hearing loss, 
tinnitus, dizziness, and an inability to rapidly equilibrate middle ear pressure.3,4 ETD is in 
most cases caused by mucosal inflammation and edema in the Eustachian tube (ET) 
lumen.5 It has been presented that sinonasal diseases, such as nasal viral upper 
respiratory tract infections,6 allergic rhinitis,7 and chronic rhinosinusitis,8 can cause 
mucosal inflammation which leads to ETD. However, the relationship between chronic 
nasal obstruction caused by inferior turbinate enlargement and ETD and the effect of 
turbinate surgery on ETD have not been evaluated previously in the literature. 
 
Many subjective and objective methods have been reported for measuring ET function, 
including otoscopic appearance, the Valsalva and Toynbee tests, tympanometry, 
tubomanometry,9 and sonotubometry.10 However, due the complexity of the functional 
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anatomy and physiology of the ET, there is still a lack of a diagnostic “gold standard” for 
obstructive ET dysfunction.4,11 
McCoul et al. have developed the Eustachian Tube Dysfunction Questionnaire (ETDQ-7), 
which is a validated, organ-specific tool for the assessment of symptoms in ETD.4 Its 
usefulness has been shown in recent studies.9,12,13 So far, it has not been used in the 
evaluation of the relationship between ETD and functional problems of the nose. 
 
The aim of this placebo-controlled study was to evaluate the effect of various inferior 
turbinate surgery techniques, such as radiofrequency ablation (RFA), diode laser, and 
microdebrider-assisted inferior turbinoplasty (MAIT), on ETD-related symptoms using the 
ETDQ-7 as an assessment method. 
 
 
MATERIALS AND METHODS 
The study was carried out at Tampere University Hospital, Tampere, Finland, between 
February 2014 and November 2016. The institutional review board approved the study 
design (R13144) and all patients provided written, informed consent. A total of 76 
consecutive adult patients with enlarged inferior turbinates due to persistent year-round 
rhinitis were enrolled in this study. The patients presented symptoms of bilateral nasal 
obstruction related to inferior turbinate congestion that had not responded to a three-month 
trial of appropriate treatment with topical corticosteroids. Patients with significant nasal 
septum deviation affecting the nasal valve region, internal/external valve collapse/stenosis, 
chronic rhinosinusitis with or without polyposis, previous nasal surgery, sinonasal tumor, 
Ménière's disease, previous ear surgery, severe systemic disorder, severe obesity, and 
malignancy were excluded.  
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Cone-beam computed tomography (CBCT) (Planmeca Max, Planmeca, Helsinki, Finland) 
was used to exclude patients with chronic rhinosinusitis from the study. Serum-specific IgE 
level measurements were used to identify the patients with an allergic sensitization. 
Allergic sensitization was defined as a specific IgE > 0.35 for any common airborne 
allergen (cat, dog, horse, birch, grass, mugwort, D. pteronyssinus, and molds).  
 
The definition of inferior turbinate enlargement was based on persistent bilateral 
symptoms, a finding of bilateral swelling of the inferior turbinates in nasal endoscopy, and 
the evident shrinking of both turbinates in a decongestion test. The nasal response 
to the topical vasoconstrictor 0.5% xylometazoline hydrochloride (Nasolin, Orion, Finland) 
in both nasal cavities 15 minutes before obtaining the second measurement was evaluated 
objectively using acoustic rhinometry (Acoustic rhinometer A1, GM instruments Ltd, 
Kilwinning, UK). An improvement of less than 30% in anterior nasal cavity volume (V2–
5 cm) – the most sensitive measure of change in mucosal swelling during decongestion14 
– in one or both nasal cavities was considered normal, and those patients were excluded 
from the study. The limit value of 30% was chosen according to previous literature.15,16,17 
 
Patients were consecutively randomized into active treatment groups (RFA, diode laser, 
MAIT) and a sham surgery group using the Minim program, which is a free MS-DOS 
program that randomizes patients into treatment groups by the method of minimization.  
 
The surgical treatment was performed in similar circumstances for all the groups in the day 
surgery department of the hospital’s ENT clinic. All surgical procedures were performed by 
the same surgeon (T.H). The staff of the day surgery section was instructed to avoid any 
kind of communication – before and during the operation, as well as during the 
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postoperative care – that might reveal the group of the patient. All the alternative surgical 
devices were available in the operation room. The procedures were carried out under local 
anesthesia with patients’ eyes covered. 
 
First, the inferior turbinates were topically anesthetized using cotton strips with a mixture of 
lidocaine 40mg/ml (Lidocain, Orion, Finland) and 2–3 drops of epinephrine 0.1% in 5–10ml 
of lidocaine. The local anesthetic (Lidocain 10mg/ml c. adrenalin, Orion, Finland) was then 
applied to the medial portions of the inferior turbinates. All the procedures were performed 
under the direct vision of a straight, 4 mm-diameter, 0-degree endoscope (Karl Storz, 
Germany). In all the groups with different techniques, the treatment was given to the 
medial side of the anterior half of the inferior turbinate. Nasal packing (Ivalon, Fabco, New 
London, Connecticut) was applied only if active bleeding developed during the surgery.  
 
The RFA treatment was carried out with a radiofrequency generator (Sutter RF generator 
BM-780 II, Freiburg, Germany). The “Binner” bipolar needle electrode was inserted into the 
medial submucosal tissue of the inferior turbinate. The upper and lower parts of the 
anterior half of the inferior turbinate were treated for 6 sec at 10W output power in three 
areas.  
 
The diode laser treatment was given with a diode laser (FOX Laser, A.R.C. LASER GmbH, 
Nuremberg, Germany). The settings were as follows: wavelength of 980nm, output power 
of 6 W in continuous-wave mode, and laser delivery by a 600μm fiber using “contact” 
mode. Four parallel stripes were made on the mucosa by drawing the fiber from the 
posterior to the anterior direction along the medial edge of the inferior turbinate.  
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In the MAIT treatment, a 2.9 mm-diameter rotatable microdebrider tip (Medtronic Xomed, 
Jacksonville, FL, USA) was firmly pushed towards the turbinate bone until it pierced the 
mucosa of the anterior face of the inferior turbinate. Next, a submucosal pocket was 
dissected by tunneling the elevator tip in an anterior to posterior and superior to inferior 
sweeping motion. Once an adequate pocket had been created, resection of the stromal 
tissue was carried out by moving the blade back and forth in a sweeping motion, with the 
system set at 3000 rpm using suction irrigation. 
 
In the sham surgery procedure, small nasal mucosal biopsies for histological and cilia 
analysis were first taken from the anterior medial portions of the inferior turbinates, causing 
minor bleeding. Next, the radiofrequency tissue ablation device was turned on repeatedly 
near the patient, but without the needle electrodes of the device touching the patient; the 
patient could only hear the acoustic tone of the device. During this sound deception, a 
suction tube and a nasal endoscope were moved lightly in both sides of the nose for a 
couple of minutes in order to convince the patient that they had undergone surgery. 
 
All the patients were evaluated prior to surgery and three months subsequent to the 
surgery. All clinical examinations were performed by the same examiner (T.H.) who was 
also the operator and not blinded to the patients’ groups. The patients filled the seven-item 
Eustachian Tube Dysfunction Questionnaire (ETDQ-7). During the control visits, the 
patients filled the questionnaire before meeting the examiner. The ETDQ-7 consists of 
seven questions with a seven-item Likert scale, with a response of 1 indicating no problem 
and 7 indicating a severe problem. The total score is divided by 7 to give an overall score 
ranging from 1.0 to 7.0.4 The questions comprising the ETDQ-7 are shown in Table 1. 
Tympanometry was also performed. The tympanometry curves were classified as follows: 
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Type A, normal Eustachian tube function; Type B, flat tympanogram, characteristic of the 
presence of fluid in the middle ear or eardrum perforation; and Type C, peak at very 
negative pressure (< -150 dPa), which may be indicative of eardrum retraction. 
Tympanometric peak pressure (TPP) – that is, the peak admittance in the tympanogram 
and an indirect measurement of middle ear pressure – was also documented.  
 
IBM SPSS Statistics 22.0 was used for the statistical analyses. All the non-parametric data 
was statistically processed using the Wilcoxon Signed Rank test. The Chi-Squared test 
was used in the evaluation of tympanometry curves. The effects of multiple factors were 
evaluated using a three-way analysis of covariance (ANCOVA).  
 
 
RESULTS 
Of the 76 patients enrolled in the study, four withdrew from the study before the operation 
took place. A total of 72 patients underwent surgery and were finally included in the study. 
The patients’ characteristics are described in Table 2. Some 45% of the patients had a 
preoperative ETDQ-7 total score of 1.0–1.9, 33% had a score of 2.0–2.9, and 22% had a 
score of 3.0 or more (range 3.1–4.4). 
 
In the active treatment groups, there were abnormal tympanometry curves in six (five type 
B and one type C) ears preoperatively and seven (six type B and one type C) ears 
postoperatively. The difference was not statistically significant. In the sham surgery group, 
there was an abnormal tympanometry curve in only one ear (type C) preoperatively, and 
there were no abnormal findings postoperatively. This difference was not significant either. 
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There were no significant changes in preoperative and postoperative TPP values among 
either the actively treated patients or the sham surgery patients (Table 3). 
 
The results of the Eustachian Tube Dysfunction Questionnaire-7 (ETDQ-7) are shown in 
Table 4. In the evaluation of all patients, RFA, MAIT, and sham surgery procedures 
decreased the total score significantly. When only patients with a preoperative score 2.0 or 
more were evaluated, all the active treatment procedures decreased the total score 
significantly.  
 
A three-way ANCOVA was run on the sample of 72 patients to examine the effect of sex, 
allergy status, and procedure group on the ETDQ-7 score change. Age was added to the 
model as a continuous covariate. In the evaluation of all patients, none of the factors had a 
significant individual main effect on the change in ETDQ-7 total score. There were no 
significant differences in the change in ETDQ-7 total score between the procedure groups, 
nor were there significant differences in the results between the sham surgery and any of 
the active treatment procedures. Allergic sensitization, sex, and age had no effect on the 
results either. The analysis was repeated for the patients with a preoperative total score 
2.0 or more, and the same results were found. 
 
 
DISCUSSION  
In previous studies, the relationship between ETD and sinonasal factors has been 
evaluated using various methods, including symptom questions,7,18 tympanometry,19,20 and 
the Toynbee and Valsalva tests.21 In order to carry out a placebo-controlled study, it is 
suitable to use a validated questionnaire if possible. In the present study, the relationship 
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between nasal obstruction and ETD-related symptoms was evaluated using the ETDQ-7, 
which is the only patient-reported outcomes tool to have undergone initial outcome 
studies. It is an organ-specific instrument for the assessment of symptoms. It can provide 
a more precise estimate of a disease burden and may yield information not readily 
identified by traditional clinical methods.4 
 
The effect of sinonasal procedures and therapies on ET function has been evaluated in a 
few previous studies. Low and Willatt evaluated the relationship between middle ear 
pressure and a deviated nasal septum. They found out that middle ear pressure ipsilateral 
to the obstructed nasal passage was negatively correlated to the degree of asymmetry of 
the patencies of the two nasal passages. Middle ear pressure improved in both ears after 
septal surgery. They postulated that post-nasal airflow turbulence associated with a 
deviated nasal septum may lead to Eustachian tube dysfunction.19 Deron et al., in turn, 
found out that correction of the septal deviation improved the passive opening pressure of 
the Eustachian tube on the deviated side similarly to the non-deviated side.22 In a 
retrospective study by Stoikes et al., symptoms of ET were found to improve or resolve in 
the majority of patients undergoing endoscopic sinus surgery.18 In their randomized, 
prospective, placebo-controlled trial, Gluth et al. evaluated the efficacy of nasal steroid 
spray in treating the tympanometric signs and symptoms of ETD. They found no 
statistically significant difference in the normalization of abnormal tympanometric signs or 
in the overall poststudy symptom score between the active treatment arm and placebo.23 
 
In the present study, the effect of inferior turbinate surgery on ETD-related symptoms was 
evaluated for the first time. The symptoms were found to improve due to inferior turbinate 
procedures. However, sham surgery improved the symptom score as effectively as real 
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surgery. Furthermore, in the subgroup with more preoperative ear symptoms, there were 
no significant differences in the ETDQ-7 total score changes between the active 
treatments and the sham surgery. In addition, there were no significant changes in the 
pre- and postoperative amounts of abnormal tympanometry curves or in the pre- and 
postoperative TPP values among actively treated patients and the sham surgery patients. 
Possible changes in TPP values may have indicated minor changes in the middle ear 
pressure as a result of the operation. The lack of improvement in TPP values in the active 
treatment group suggests that the reduction of the anterior part of the inferior turbinate 
does not have even a minor effect on ET function. It is likely that in chronic inferior 
turbinate enlargement, the nasal mucosal edema – which can originally be caused by 
environmental allergens or non-allergic, non-specific triggers – can expand to the 
nasopharyngeal ET orifice, disturbing ET function. Based on the present study, the 
surgical treatment of the anterior part of the inferior turbinate did not have any real effect 
on the nasopharyngeal ET orifice and possible ETD.  
 
The internal nasal valve area is the narrowest portion of the upper nasal airway, and the 
anterior portion of the inferior turbinate is the predominant structure in this part of the nose; 
therefore, it plays a major role in nasal obstruction.2,24 Surgical treatment of the anterior 
part of the inferior turbinate has been found to be effective in decreasing nasal 
obstruction.25 The posterior part of the turbinate, which is anatomically located very close 
to ET orifice, was not operated on in the present study. The idea of this study was also to 
compare the efficacy of various inferior turbinate surgery techniques in the treatment of the 
problem. In order to make the procedures as comparable as possible we treated the same 
length of the turbinate with every technique. The easiest way to guarantee that was to limit 
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the operation to the anterior part of the inferior turbinate because in some cases it can be 
difficult to operate the posterior part of the turbinate under local anesthesia. 
 
In the present study, the patients’ main problem was nasal obstruction. Ear symptoms 
were not their major concern in the first place. The aim of this study was to examine 
possible ETD-related symptoms among the patients and the effect of inferior turbinate 
surgery on the symptoms. A recent consensus statement defining ETD agreed that to 
diagnose dilatory Eustachian tube dysfunction, patient-reported symptoms should go 
together with evidence of negative pressure in the middle ear.26 In the present study, more 
than half of the patients had an ETDQ-7 score of 2.0 or more, and more than one fifth of 
the patients had a score of 3.0 or more, which represents the same severity of symptoms 
as patients found to have ETD in the study by McCoul et al. However, only less than 10% 
of the patients enrolled had an abnormal tympanogram (type B or C) confirming the 
diagnosis of ETD. A clear weakness of ETDQ-7, in turn, is that it cannot discriminate 
between patients with obstructive ET dysfunction and patulous ET. Therefore, it cannot be 
used as a sole criterion for the diagnosis of ETD. For these reasons we are not able to 
generalize the results of this study to ETD. We can only talk about the effect of inferior 
turbinate procedure on patients' symptoms suggestive of ETD. 
 
All clinical examinations and operations were performed by the same physician, who 
was not blinded to the patients’ groups. Unblinding of the examining physician could 
introduce unintentional bias by causing misinterpretation of data. However, the 
examination parameters used in this study were not based on the subjective evaluation 
of the examining physician. Parameters of tympanometry, unlike otoscopic appearance or 
Valsalva and Toynbee tests, are not based on the subjective evaluation of the examiner. 
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That is why tympanometry was chosen to be the only objective examination method in this 
study. However, it is sometimes very challenging to make a confirmed diagnosis of ETD 
based on both patient-reported symptoms and signs of negative pressure in the middle ear 
in the form of abnormal tympanometry curves. In mild or fluctuating cases, the patients 
may have symptoms suggestive of ETD but their tympanometry curves can be within 
normal limits.  
 
 
CONCLUSION 
The improvement of ETD-related symptoms due to surgery of the anterior half of the 
inferior turbinate was found to be equal to placebo. The findings of this study do not 
support the use of reduction of the anterior half of the inferior turbinate as a sole procedure 
intended to treat the ear symptoms assessed by the ETDQ-7 questionnaire. 
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Table 1. Eustachian Tube Dysfunction Questionnaire-7 
(ETDQ-7) questions. 
   1. Pressure in the ears? 
   2. Pain in the ears? 
   3. A feeling that your ears are clogged? 
   4. Ear symptoms when you have a cold or sinusitis? 
   5. Crackling or popping sounds in the ears? 
   6. Ringing in the ears? 
   7. A feeling that your hearing is muffled? 
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Table 2. Patients’ characteristics. 
Age (years), Mean (range)  44 (23–69) 
Sex  
   Male, No. (%) 42 (58) 
   Female, No. (%) 30 (42) 
Allergic sensitization  
   Yes, No. (%) 28 (39) 
   No, No. (%) 44 (61) 
Technique  
   RFA, No. (%) 20 (28) 
   Diode laser, No. (%) 18 (25) 
   MAIT, No. (%) 23 (32) 
   Sham surgery, No. (%) 11 (15) 
Preoperative ETDQ-7 total score  
   1.0–1.9, No. (%) 32 (45) 
   2.0–2.9, No (%) 24 (33) 
   3.0 or more, No. (%) 16 (22) 
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Table 3. Tympanometry results (N = 144 ears). 
 Preoperative Postoperative 
Abnormal tympanometry (B or C)   
   Active treatment groups (N = 122), No. (%) 6 (5) 7 (6)* 
   Sham surgery group (N = 22), No. (%) 1 (5) 0 (0)* 
Tympanometric peak pressure (dPa)   
   Active treatment groups, median (IQR) -4.0 (-15.0–14.0) -4.0 (-15.0–2.0)** 
   Sham surgery group, median (IQR) -8.0 (-16.5–16.3) -5.0 (-16.5–14.5)** 
      IQR = interquartile range (Q25–Q75) 
      *Not significant, Chi-squared test 
      **Not significant, Wilcoxon Signed Rank test 
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Table 4. Results of the ETDQ-7. 
All patients 
 Preoperative 
ETDQ-7, Median 
(IQR) 
Postoperative 
ETDQ-7, Median 
(IQR) 
ETDQ-7 change, 
mean (95% CI) 
p-value 
Procedure     
All active treatments, 
n = 61 
2.1 (1.4–2.9) 1.7 (1.2–2.1)  -0.4 (-0.6–-0.2) <0.001* 
   RFA, n = 20 2.5 (1.3–3.3) 1.7 (1.5–2.3) -0.4 (-0.8–-0.02) 0.03* 
   Diode laser, n = 18 1.6 (1.3–2.4) 1.4 (1.1–1.9) -0.3 (-0.6–0.01) 0.06 
   MAIT, n = 23 2.4 (1.6–3.3) 1.9 (1.3–2.4) -0.5 (-0.9–-0.2) 0.006* 
   Sham surgery, n = 11 2.1 (1.4–2.9) 1.4 (1.3–2.1) -0.5 (-0.9–-0.1) 0.04* 
Preoperative ETDQ-7 total score 2.0 or more 
Procedure     
All active treatments, 
n = 34 
2.9 (2.4–3.4) 2.0 (2.43.4) -0.8 (-1.0–-0.5) <0.001* 
   RFA, n = 12 2.9 (2.6–3.7) 2.1 (1.6–3.4) -0.8 (-1.4–-0.2) 0.02* 
   Diode laser, n = 7 2.6 (2.1–2.9) 1.9 (1.3–2.3) -0.7 (-1.3–-0.2) 0.02* 
   MAIT, n = 15 3.1 (2.4–3.3) 2.0 (1.6–2.4) -0.8 (-1.3–-0.3) 0.01* 
   Sham surgery, n = 6 2.8 (2.1–3.6) 2.1 (1.7–2.6) -0.7 (-1.4–-0.02) 0.08 
      IQR = Interquartile range (Q25–Q75) 
      *Statistically significant, Wilcoxon Signed Rank test 
 
